Pharma Event Intelligence Platform
Track global conferences, regulatory summits, and clinical congresses with coverage, company intelligence, and networking signals.
United States & Americas Pharma Events
FDA-regulated pharmaceutical news, drug approvals, and clinical trial updates for the US and Americas market. Track FDA-market congresses, regulatory summits, and clinical meetings with NovaPharmaNews coverage.
What's moving in Americas
13 congresses live in Americas
Active now: DIA · DIA. NovaPharmaNews is tracking presentations and company signals in real time.
4 events in the next 14 days
A dense catalyst window for FDA-market BD, investor positioning, and clinical data anticipation.
8 tier-1 conferences through 60 days
Major congresses drive pipeline narratives, licensing windows, and sell-side estimate revisions across United States & Americas.
General leads the Americas calendar
4 upcoming events cluster in general — the highest sector density in the next 60 days.
1 regulatory summit on deck
FDA policy, compliance, and submission strategy forums for regulatory affairs and market access teams.
16 presentations indexed
12 companies mapped across upcoming Americas congresses — pipeline and investor-impact scoring applied.
Why Americas pharma events matter now
United States & Americas pharma events are not calendar entries — they are catalyst clusters where clinical data, regulatory posture, and partnership timing converge. In the next 60 days, 8 tier-1 conferences and 4 near-term meetings shape how investors and BD teams allocate attention across the FDA corridor.
The highest-conviction watchlist centers on DIA, BIO, RESI San Diego. These congresses historically move consensus estimates, trigger licensing conversations, and surface competitive readouts that ripple into 12–18 month pipeline valuations.
NovaPharmaNews links 190+ published articles to this calendar — combining presentation intelligence, company mapping, and editorial analysis rather than republishing organizer agendas.
Prioritize tier-1 congresses (8 in 60 days) where management commentary and data readouts reset guidance.
Use live and pre-event windows for partnering — 12 companies already indexed across upcoming programs.
1 regulatory forums plus therapeutic-area congresses set submission strategy and trial-design benchmarks for FDA markets.
How to read this page
Two sections serve different intelligence needs. Live Events are active congresses; Major Conferences are editor-selected tier-1 planning priorities on the FDA calendar.
Live Events
Congress in session right now across Americas. These are active catalyst windows — not upcoming listings.
- Real-time presentation and company signals as sessions run
- Breaking coverage and data-readout alerts where editorial is filed
- Highest urgency for investors monitoring same-day market moves
Major Conferences
Editorially curated tier-1 congresses on the FDA calendar — selected for market-moving history, attendance scale, and pipeline density.
- Tier-1 global or major designation — not every regional meeting
- Pre-event briefs, key-data previews, and investor-impact scoring
- Planning horizon: BD outreach, travel, and competitive intelligence prep
Most important events — next 60 days
- 1 DIA Live now
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across regulatory, clinical, …
- 2 BIO Jun 22 – 25, 2026
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
- 3 RESI San Diego Jun 22 – 23, 2026
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partn…
- 4 Drug Discovery USA Jun 16 – 17, 2026
This free-to-attend, Pfizer-hosted ELRIG conference signals a strategic push to bridge European and US drug discovery communities specifically around multifunct…
- 5 AACR/ASCO Methods in Clinical Jul 26 – 31, 2026
The AACR/ASCO Methods in Clinical Cancer Research Workshop (July 26-31, 2026, Vail, Colorado) is a highly selective, intensive training program for early-career…
- 6 APPOS Austin Jul 17 – 18, 2026
APPOS Austin 2026 is a dedicated two-day CME summit for advanced practice providers (NPs, PAs, pharmacists) in oncology, focusing on evidence-based strategies f…
- 7 Cardinal Health RBC Jul 22 – 25, 2026
The Cardinal Health Retail Business Conference 2026 in Orlando is the primary annual gathering for the largest US pharmaceutical distributor's independent pharm…
- 8 2026 TPA Conference Jul 24 – 26, 2026
The 2026 Texas Pharmacy Association (TPA) Conference & Expo is a key state-level gathering focused on pharmacy practice, technician workforce development, and p…
Companies most active across events
Sponsors and presenters with the broadest congress footprint in Americas over the next 60 days.
- 1
Presenting at 2 congresses — broad Q2 visibility across BIO, Drug Discovery USA.
BIO · Drug Discovery USA
- 2
- 3
- 4
- 5
Single high-signal presentation at BIO with elevated investor-impact score.
BIO
- 6
Single high-signal presentation at RESI San Diego with elevated investor-impact score.
RESI San Diego
- 7
- 8
Drug pipelines to watch
INN-level readouts indexed from upcoming congress abstracts — ranked by investor-impact score.
- 1pelacarsenNovartisImpact 5/5
On the BIO, Drug Discovery USA agenda (Phase Iii) in Cardiovascular disease (elevated Lp(a)) — high investor-impact readout.
Phase Iii · Cardiovascular disease (elevated Lp(a)) · cardiovascular disease (elevated lipoprotein(a))
- 2
On the DIA agenda (Phase Iii) in 1L hepatocellular carcinoma — high investor-impact readout.
Phase Iii · 1L hepatocellular carcinoma
- 3
On the DIA agenda (Phase Iii) in relapsed/refractory diffuse large B-cell lymphoma — high investor-impact readout.
Phase Iii · relapsed/refractory diffuse large B-cell lymphoma
- 4VRDN-008Viridian Therapeutics
On the Drug Discovery USA agenda (Phase I) in Healthy volunteers (Phase 1).
Phase I · Healthy volunteers (Phase 1)
- 5rese-celCabaletta Bio
On the RESI San Diego agenda (Phase I) in Dermatomyositis.
Phase I · Dermatomyositis
Therapeutic area intelligence
Where congress density, tier-1 flagships, and presentation coverage cluster in Americas.
BIO · RESI San Diego
2 upcoming biotech events (2 tier-1) — flagship: BIO, RESI San Diego. 11 presentations indexed. Biotech forums concentrate partnering, financing, and early-stage pipeline narratives ahead of IND and Phase I milestones.
DIA
1 upcoming regulatory events (1 tier-1) — flagship: DIA. 3 presentations indexed. Regulatory summits set submission strategy, inspection readiness, and agency interaction benchmarks for the next review cycle.
2026 TPA Conference · APPOS Austin · Cardinal Health RBC · Drug Discovery USA
4 upcoming general events (4 tier-1) — flagship: 2026 TPA Conference, APPOS Austin, Cardinal Health RBC, Drug Discovery USA. 2 presentations indexed. Cross-therapeutic congresses attract diversified BD pipelines — useful for platform deals and multi-indication licensing.
AACR/ASCO Methods in Clinical
1 upcoming oncology events (1 tier-1) — flagship: AACR/ASCO Methods in Clinical. Oncology congresses drive the highest density of registrational readouts and label-expansion catalysts — priority for investors and clinical teams.
Desk notes on upcoming congresses
Investor, regulatory, and competitive implications distilled from event intelligence — not organizer marketing copy.
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across regulatory, clinical, medical affairs, quality, safety, and digital health.…
FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at regulatory leadership forums.
Competitive positioning among top regulatory players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Expect signals on pricing, formulary strategy, and partnership economics relevant to regulatory markets in the US region.
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across regulatory, clinical, medical affairs, quality, safety, and digital health.…
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across regulatory, clinical, medical affairs, quality, safety, and digital health.…
Congress intelligence by desk
Clinical readouts, FDA forums, partnering windows, and market-moving congresses — curated for Americas, not a raw directory export.
Clinical data calendar
Indexed abstracts, trial phases, and NCT-linked readouts across upcoming congresses.
- pelacarsenlate-breakerPhase IiiImpact 5Phase 3 Lp(a)HORIZON study results for pelacarsen
- pelacarsenlate-breakerPhase IiiImpact 5Phase III Lp(a)HORIZON study of pelacarsen: top-line results
- glofitamab(Columvi)oralPhase IiiImpact 5STARGLO: Phase 3 trial comparing glofitamab plus gemcitabine and oxaliplatin with rituximab plus gemcitabine
- oralPhase IiiImpact 4Top-line Data Readout of the Twin Phase 3 ENSURE Trials
- oralPhase IiiImpact 4Phase III data readouts for key studies in oncology (H1 and H2 2026)
- oralPhase Ii1-Year Data from the REVEAL-1 Cohort of Revita
Regulatory events calendar
FDA summits, DIA forums, and compliance congresses for regulatory affairs teams.
- DIAJun 14 – Jun 18, 2026Philadelphia
In session or imminent — FDA policy, submission strategy, and compliance forum (tier-1). 4 linked coverage articles.
Partnership & licensing events
BIO, partnering summits, and BD forums where deal flow concentrates.
- BIOJun 22 – Jun 25, 2026Tier 1
Flagship BD partnering forum — licensing, co-development, and platform deal-making at global scale.
Market-moving conferences
Ranked by editorial coverage, abstract density, and tier-1 designation — investor desk priority.
- 1BIO136Jun 22 – Jun 25, 2026
Market-moving score 136 (tier-1 · 3 articles · 5 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 2DIA116Jun 14 – Jun 18, 2026
Market-moving score 116 (tier-1 · 4 articles · 3 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 3Jun 22 – Jun 23, 2026
Market-moving score 96 (tier-1 · 1 articles · 6 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 4Jun 16 – Jun 17, 2026
Market-moving score 94 (tier-1 · 1 articles · 2 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 5Jul 26 – Jul 31, 2026
Market-moving score 56 (tier-1) — historically drives estimate revisions and sector rotation.
- 6Jul 17 – Jul 18, 2026
Market-moving score 50 (tier-1) — historically drives estimate revisions and sector rotation.
Build your event watchlist
Follow congresses, companies, pipeline programs, or therapeutic areas. Weekly digest + catalyst alerts — no account required.
Live in Americas
Congress in session now — real-time catalyst window for data readouts and coverage.
DIA
• Jun 14 – Jun 18, 2026
DIA shapes strategic priorities for regulatory stakeholders through 2026–2027.
DIA
• Jun 14 – Jun 18, 2026
DIA shapes strategic priorities for regulatory stakeholders through 2026–2027.
DIA
• Jun 14 – Jun 18, 2026
DIA shapes strategic priorities for regulatory stakeholders through 2026–2027.
DIA
• Jun 14 – Jun 17, 2026
DIA shapes strategic priorities for regulatory stakeholders through 2026–2027.
DIA
• Jun 14 – Jun 17, 2026
DIA shapes strategic priorities for general stakeholders through 2026–2027.
Major Americas Conferences
Editor-selected tier-1 congresses — planning priorities, not a complete directory.
DIA
Philadelphia, USA • Jun 14 – Jun 18, 2026
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across re…
Drug Discovery USA
Cambridge, USA • Jun 16 – Jun 17, 2026
This free-to-attend, Pfizer-hosted ELRIG conference signals a strategic push to bridge European and US drug discovery communities specifical…
BIO
San Diego, USA • Jun 22 – Jun 25, 2026
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
RESI San Diego
San Diego, USA • Jun 22 – Jun 23, 2026
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three d…
APPOS Austin
Austin, Texas • Jul 17 – Jul 18, 2026
APPOS Austin 2026 is a dedicated two-day CME summit for advanced practice providers (NPs, PAs, pharmacists) in oncology, focusing on evidenc…
Cardinal Health RBC
Orlando, United States • Jul 22 – Jul 25, 2026
The Cardinal Health Retail Business Conference 2026 in Orlando is the primary annual gathering for the largest US pharmaceutical distributor…
No upcoming events in Americas. Browse all global events.
Recently Concluded — Americas
June 2026
APPOS Hartford
Hartford, Connecticut • Jun 12 – Jun 13, 2026
APPOS Hartford 2026 is a dedicated summit for advanced practice providers (NPs, PAs, pharmacists) in oncology, focusing on multidisciplinary…
ASCO 2026
Chicago, United States • Jun 5 – Jun 9, 2026
The 2026 ASCO Annual Meeting is The Place to Be.
CPhI
Philadelphia, USA • Jun 3 – Jun 4, 2026
Breaking Barriers: Women's Networking .
THMA Pharmacy Growth
Carlsbad, USA • Jun 3 – Jun 5, 2026
The Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .…
May 2026
ASCO
Chicago, USA • May 29 – Jun 2, 2026
The 2026 ASCO Annual Meeting is The Place to Be.
Navigating the Data
Boston, USA • May 20 – May 21, 2026
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at …
Clinical Research Patient
TBD, USA • May 19 – May 20, 2026
Join us at the 28th Precision in Clinical Trials Summit Boston (PCT) for a two-day journey into the insightful world of clinical trials.…
Regulatory Education for
Not specified • May 19 – May 20, 2026
Conference on Innovative Regulatory Strategies to Advance Medical Products, covering topics like Advanced Drug Manufacturing, AI in Drug Dev…
ReDI 2026 Conference
Not specified • May 19 – May 20, 2026
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at …
Pharma Manufacturing World
Boston, United States • May 18 – May 20, 2026
Premier gathering for pharmaceutical manufacturing leaders to explore innovative strategies, emerging trends, and best practices.…
ScopeX
Boston, USA • May 18 – May 19, 2026
On Wednesday, April 29, 2026, the FDA is hosting a free public webinar to provide updates on RCT-DUPLICATE, one of FDA’s demonstration proje…
ISPOR 2026
Philadelphia, USA • May 17 – May 20, 2026
Leading international conference featuring poster presentations and exhibits on pharmacoeconomics and clinical research.…
Bio-IT World Conference
Boston, USA • May 15 – May 17, 2026
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at …
SCOPE X 2026
Boston, United States • May 15 – May 17, 2026
<p><strong>Meet us at booth #1 </strong></p> <p>SCOPE X is a two-day gathering being held in Boston, bringing together clinical research lea…
BBSW AI Solution
Foster, USA • May 15 – May 16, 2026
C-Path works with the FDA and European Medicine Agency (EMA) to accelerate the pace of medical product development while reducing related ri…